Tagged with export

Poland The value of Poland’s pharmaceutical exports shot from USD 501 million in 2005 to USD 3.475 billion in 2015, a total growth of an astounding 590% and a compound annual growth rate of 21%. Most exports go to Europe (80%) but Asian markets are becoming increasingly important to Poland and…

India Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub and gives us his assessment of the recent plateauing of Indian exports as well as an overview of the new…

India In this exclusive interview, Binish Chudgar, vice-chairman and managing director of Intas, the largest privately-owned Indian pharmaceutical company with sales of over USD 1.7 billion during the last financial year, provides insights into the company’s growth model and M&A approach, as well as his objectives with regards to a large-scale…

Poland Colm Murphy, general plant manager of Anpharm, a key European production site for the Servier group, highlights major investments in recent years, such as the state-of-the-art QC Lab, and his strategy to increase the plant’s exports. Additionally, he discusses the growing importance of the company’s CDMO activities and the steps…

Canada Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs.   Key areas of expenditure in Canadian medtech: diagnostic imaging stands as the single largest therapeutic area served.   Canadian medical device export destinations; the US is far and away the largest market for Canadian…

India Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and emerging markets as well as the opportunities that Cipla sees as a specialty pharmaceutical company in the US.   The opportunity to service such a vast patient…

Tunisia Ridha Charfeddine, founding CEO of Unimed and president of the National Chamber of the Pharmaceutical Industry (CNIP) discusses enforcing European quality standards in Tunisia, the CNIP’s role in guiding pharmaceutical and medical device companies in Tunisia, as well as his entrepreneurial journey with Unimed, now the preferred partner of the…

Ukraine Ludmila Bezpalko, CEO of Borshchahivskiy Chemical Pharmaceutical Plant (BCPP), a top 10 domestic pharmaceutical company in Ukraine, documents the development strategy she has been following over the past two decades to ensure BCCP now proudly stands as the Ukrainian leader in terms of international standards and quality certifications. She also…

Ireland Despite a comparatively small population by European standards, Ireland’s macroeconomic indicators remain healthy, with strong GDP growth rates. Ireland is globally competitive in terms of flexibility, adaptability, human resources, culture, and economic policy. Ireland’s tax regime is also globally competitive, with favourable corporate tax rates, R&D tax credit, and an…

Poland Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the eighth largest economy in Europe according to the World Bank. The introduction into Europe has sprung the borders open, and for the Polish pharmaceutical industry this…

Europe Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North America. The biopharmaceutical industry is a key contributor to the European economy in terms of both trade surplus and employment; especially highly-skilled R&D jobs. Germany is…

Greece Vassilios Katsos, President & CEO of Pharmathen, articulates the philosophy that has led to the company’s strong market positioning: innovation, internationalization and investment. Based on this triumvirate of strategies, he describes Pharmathen’s ability to keep pace with the global market while maintaining a focus on R&D and operational excellence. As one…